![](/img/cover-not-exists.png)
RBTT-03. A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF AG-120 (IVOSIDENIB) AND AG-881 IN PATIENTS WITH RECURRENT, NONENHANCING, IDH1-MUTANT, LOW-GRADE GLIOMA
Mellinghoff, Ingo, Maher, Elizabeth, Wen, Patrick, Cloughesy, Timothy, Peters, Katherine, Choi, Changho, Ellingson, Benjamin, Lin, Alexander, Li, Yan, Soher, Brian, Young, Robert, Steelman, Lori, Le,Volume:
20
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noy148.973
Date:
November, 2018
File:
PDF, 86 KB
2018